Jan 23, 2019

Report: Reskilling workers due to automation will cost $34 billion

Making control units for tanks and airplanes in 1943. Photo: FPG/Hulton Archive/Getty

The U.S. government and private companies will need to pay $34 billion to reskill 1.4 million workers who may lose their jobs to automation in the coming years, according to a new report from the World Economic Forum.

Yes, but: Most of that cost will have to be covered by the government because only about 25% of it will be cost-efficient for business, Saadia Zahidi, managing director of the World Economic Forum, told Axios.

What's happening: The World Economic Forum, meeting this week in Davos, Switzerland, sought to put a dollar amount on the fundamental reskilling of the workforce that will be necessary against a huge wave of automation presumed to be on its way.

  • The 1.4 million displaced workers due to robotization, an estimate originally from the U.S. Bureau of Labor Statistics, is a fraction of what prior major forecasts estimated, including Oxford University and the McKinsey Global Institute.
  • Zahidi says that if the larger estimates are right, the cost of reskilling will be that much higher.
  • Many of those to be displaced will have to learn entirely different occupations, according to the report.

The report also said that 18% of those displaced, or 252,000 people, will not be reskillable economically, so the government will have to step in with public assistance.

Go deeper

Pandemic forces startups to shift gears

Illustration: Eniola Odetunde/Axios

Spaces CEO Brad Herman had an early warning about COVID-19 because his startup supplies VR attractions to a number of theme parks in China. Realizing that the business he spent the last few years building was going to evaporate, Herman quickly found a new way to apply his team's know-how: helping companies host Zoom teleconferences in VR.

Why it matters: Many startups are rethinking the viability of their core businesses in the wake of the coronavirus. Spaces' move is one of many such pivots likely to crop up in the coming months.

International coronavirus treatment trial uses AI to speed results

Hydroxychloroquine is one of the drugs that will be included in the trial. Photo: John Philips/Getty Images

The first hospital network in the U.S. has joined an international clinical trial using artificial intelligence to help determine which treatments for patients with the novel coronavirus are most effective on an on-going basis.

Why it matters: In the midst of a pandemic, scientists face dueling needs: to find treatments quickly and to ensure they are safe and effective. By using this new type of adaptive platform, doctors hope to collect clinical data that will help more quickly determine what actually works.

We can't just flip the switch on the coronavirus

Illustration: Sarah Grillo/Axios

It feels like some big, terrible switch got flipped when the coronavirus upended our lives — so it’s natural to want to simply flip it back. But that is not how the return to normalcy will go.

The big picture: Even as the number of illnesses and deaths in the U.S. start to fall, and we start to think about leaving the house again, the way forward will likely be slow and uneven. This may feel like it all happened suddenly, but it won't end that way.